In Vitro-In Vivo Correlation Evaluation of Generic Alfuzosin Modified Release Tablets

Alfuzosin, a selective alpha-1a antagonistis is the most recently approved AARAS, with limited cardiac toxicity and exclusively used for lower urinary tract syndromes (LUTS). In order to reduce pill burden and better patient compliance modified release (MR) formulations have been developed. Alfuzosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanki, Utpal Kumar, Mandal, Badal Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671720/
https://www.ncbi.nlm.nih.gov/pubmed/23762637
http://dx.doi.org/10.5402/2012/813836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671720/
https://www.ncbi.nlm.nih.gov/pubmed/23762637
http://dx.doi.org/10.5402/2012/813836

Ejemplares similares